Bajerski L - Search Results

1

Structural elucidation of gemifloxacin mesylate degradation product.

Paim CS, Führ F, Martins MT, Gnoatto S, Bajerski L, Garcia CV, Steppe M, Schapoval EE. Paim CS, et al. Among authors: bajerski l. Biomed Chromatogr. 2016 Mar;30(3):459-65. doi: 10.1002/bmc.3569. Epub 2015 Sep 2. Biomed Chromatogr. 2016. PMID: 26205148

2

Simple HPLC-UV for the quantification of a new leishmanicidal candidate (E)-1-4(trifluoromethyl) benzylidene)-5-(2-4-dichlorozoyl) carbonylhydrazine (LASSBio-1736) in rat plasma for pharmacokinetics assessment.

Moraes BKS, Bajerski L, Parisotto A, Silva CEDR, Alves MA, Barreiro EJ, Freddo RJ, Dalla Costa T, Lima LM, Haas SE. Moraes BKS, et al. Among authors: bajerski l. Biomed Chromatogr. 2016 Jul;30(7):1029-1035. doi: 10.1002/bmc.3646. Epub 2016 Jan 3. Biomed Chromatogr. 2016. PMID: 26542632

3

Bilastine: Quantitative Determination by LC with Fluorescence Detection and Structural Elucidation of the Degradation Products Using HRMS.

Motta PR, Dos Santos Porto D, Martini PRR, Bajerski L, Azeredo JB, Paula FR, Paim CS. Motta PR, et al. Among authors: bajerski l. J AOAC Int. 2020 Nov 1;103(6):1451-1460. doi: 10.1093/jaoacint/qsaa059. J AOAC Int. 2020. PMID: 33247742

4

Empagliflozin: Validation of Stability-Indicating LC Method and in silico Toxicity Studies.

da Silva AT, Brabo GR, Porto DDS, da Silva Jonco J, Bajerski L, Paula FR, Paim CS. da Silva AT, et al. Among authors: bajerski l. J Chromatogr Sci. 2024 Feb 2;62(2):132-139. doi: 10.1093/chromsci/bmac106. J Chromatogr Sci. 2024. PMID: 36585772

5

Development and validation of discriminating method of dissolution for fosamprenavir tablets based on in vivo data.

Rossi RC, Dias CL, Bajerski L, Bergold AM, Fröehlich PE. Rossi RC, et al. Among authors: bajerski l. J Pharm Biomed Anal. 2011 Feb 20;54(3):439-44. doi: 10.1016/j.jpba.2010.09.004. Epub 2010 Sep 15. J Pharm Biomed Anal. 2011. PMID: 20943342

6

Determination of omeprazole in bulk and injectable preparations by liquid chromatography.

Schubert A, Werle AL, Schmidt CA, Codevilla C, Bajerski L, Chiappa R, Cardoso SG. Schubert A, et al. Among authors: bajerski l. J AOAC Int. 2003 May-Jun;86(3):501-4. J AOAC Int. 2003. PMID: 12852566

7

Development and validation of a discriminating in vitro dissolution method for a poorly soluble drug, olmesartan medoxomil: comparison between commercial tablets.

Bajerski L, Rossi RC, Dias CL, Bergold AM, Fröehlich PE. Bajerski L, et al. AAPS PharmSciTech. 2010 Jun;11(2):637-44. doi: 10.1208/s12249-010-9421-0. Epub 2010 Apr 7. AAPS PharmSciTech. 2010. PMID: 20373150 Free PMC article.

8

Determination of amlodipine in pharmaceutical dosage forms by liquid chromatography and ultraviolet spectrophotometry.

Malesuik MD, Cardoso SG, Bajerski L, Lanzanova FA. Malesuik MD, et al. Among authors: bajerski l. J AOAC Int. 2006 Mar-Apr;89(2):359-64. J AOAC Int. 2006. PMID: 16640284

9

A Review of Characteristics, Properties, Application of Nanocarriers and Analytical Methods of Luliconazole.

Dos Santos Porto D, Bajerski L, Donadel Malesuik M, Soldateli Paim C. Dos Santos Porto D, et al. Among authors: bajerski l. Crit Rev Anal Chem. 2022;52(8):1930-1937. doi: 10.1080/10408347.2021.1926219. Epub 2021 May 19. Crit Rev Anal Chem. 2022. PMID: 34011234 Review.

10

Liquid chromatographic determination of cetirizine in oral formulations.

Bajerski L, Cardoso SG, Diefenbach IF, Malesuik MD, Sílvia H, Borgmann M. Bajerski L, et al. J AOAC Int. 2005 Mar-Apr;88(2):424-7. J AOAC Int. 2005. PMID: 15859066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters